查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
感染监控解决方案市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品（软体、服务）、最终用户（医院、长期照护设施）、地区和竞争细分
市场调查报告书
商品编码
1370959

感染监控解决方案市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品（软体、服务）、最终用户（医院、长期照护设施）、地区和竞争细分

Infection Surveillance Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Offering (Software, Service), By End User (Hospitals, Long-term Care Facilities), By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 190 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022 年，全球感染监测解决方案市场估值达到 5.5721 亿美元，并预计在预测期内强劲增长，预计复合年增长率 (CAGR) 为 11.16%，预计到 2028 年将达到 105198 万美元。感染监测解决方案是包括医院在内的医疗机构使用的软体，用于向州和联邦当局报告病患资料。这些解决方案透过收集医院感染资料、研究感染模式并调节其在社区内的传播，在医疗保健产业中发挥着至关重要的作用。院内感染是指在医院或医疗中心内传播给个人的感染。一旦发生感染，该软体会立即向医院的互联网协议 (IP) 地址发出警报，使 HAI 专家和护士能够及时为受感染的患者提供适当的治疗，防止疫情爆发。感染监测解决方案是促进医疗机构中医疗保健获得性感染 (HAI) 有效管理的重要计划。 HAI 的常见例子包括肺炎、胃肠道疾病、泌尿道感染、原发性血流感染和手术后感染。医院感染的高发生率是世界各国政府关注的重大议题，因此制定了旨在有效管理和减少这些事件的政策。

主要市场驱动因素：

  • 1.医院获得性感染盛行率不断上升：医院获得性感染 (HAI) 盛行率不断上升，推动了对感染监测解决方案的需求。 HAI，也称为医疗保健相关感染，是患者在医疗机构接受治疗时发生的感染。这些感染可能导致住院时间延长、医疗费用增加、病患不适，严重时甚至导致死亡。为了应对这一日益增长的担忧，人们正在寻求感染监测解决方案来帮助预防、监测和管理 HAI。
市场概况
预测期 2024-2028
2022 年市场规模 5.5721亿美元
2028 年市场规模 105198万美元
2023-2028 年复合年增长率 11.16%
成长最快的细分市场 重症监护室/重症监护室
最大的市场 北美洲
  • 2.手术数量的增加：手术数量的增加推动了对感染监测解决方案的需求。手术有术后感染的风险，可能导致併发症、延长住院时间、增加医疗费用和患者不适。感染监测解决方案在监测和预防医院感染（包括外科手术后发生的医院感染）方面发挥关键作用。外科手术会将病原体引入体内，增加手术部位感染的风险。感染监测解决方案可协助医疗机构监测手术部位并及早发现感染，以便及时采取介入措施。
  • 3.政府对跨医疗机构的 IPC 计划的倡议和投资不断增加：世界各地的政府正在实施政策和法规，以製定长期感染预防和控制计划，并就最佳实践对医疗保健提供者进行教育。除了维护公共统计记录外，政府还向医疗中心和组织提供资金，用于安装先进的感染监测软体。这些措施使不同规模的医疗机构能够有效地利用尖端工具，促进感染控制监测解决方案市场的成长。
  • 4.透过人工智慧整合增加投资以改善医疗保健系统：对医疗保健系统的投资优先考虑病人安全和护理品质。感染监测解决方案在识别和预防 HAI 方面发挥着至关重要的作用，有助于改善病患安全结果。医疗保健系统正致力于品质改善倡议，以减少不良事件，包括医院感染。由于住院时间延长、额外治疗和再次入院，医院感染导致医疗费用增加。对感染监测解决方案的投资可以透过预防感染及其相关併发症来显着节省成本。
  • 5.基于云端的软体解决方案：基于云端的软体解决方案预计将在未来显着推动感染监控解决方案（ISS）市场的发展。云端技术提供可扩展性、节省成本和远端存取优势，非常符合医疗保健组织寻求高效且可扩展的感染监测解决方案的需求。
  • 6.医疗保健产业的整合不断加强：医疗保健产业的整合不断加强，预计将推动感染监测解决方案(ISS) 市场的发展，因为医疗保健组织寻求ISS 等标准化实践和技术解决方案，以确保对感染进行一致的监测和管理。

细分洞见：

产品类型洞察：市场分为软体和服务。 2022 年，软体细分市场占据主导地位，而服务细分市场预计将在预测期内表现出更高的复合年增长率 (CAGR)。软体领域的成长可归因于不同配置的可用性、快速投资回报和即时分析等优势。

最终用户洞察：医院代表着最大的市场份额，并且在预测期内呈现最高的成长率。包括手术部位感染 (SSI) 在内的医疗保健相关感染 (HAI) 的盛行促进了医院市场的成长。

  • 塞纳公司
  • 史诗系统公司
  • 维吉兰兹公司
  • 贝克顿迪金森公司
  • 普瑞米尔公司
  • DEB集团有限公司
  • 强化学习解决方案
  • 百特国际公司（ICNet International）
  • 五条工业公司
  • IBM 公司（特鲁文健康分析）

报告范围：

在本报告中，除了以下详细介绍的产业趋势外，全球感染监控解决方案市场也分为以下几类。

感染监控解决方案市场，透过提供：

  • 软体
  • 服务

感染监控解决方案市场，依最终用户划分：

  • 医院
  • 长期照护设施

感染监控解决方案市场（按地区）：

  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 欧洲
  • 法国
  • 英国
  • 义大利
  • 德国
  • 西班牙
  • 亚太
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 南美洲
  • 巴西
  • 阿根廷
  • 哥伦比亚
  • 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 科威特
  • 土耳其
  • 埃及

竞争格局

  • 公司概况：对全球感染监控解决方案市场中主要公司的详细分析。

可用的客製化：

  • 全球感染监测解决方案市场报告以及给定的市场资料，TechSci Research 根据公司的具体需求提供客製化服务。该报告可以使用以下自订选项：

公司资讯

  • 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球感染监测解决方案市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品（软体、服务）
    • 依最终使用者（医院、长期照护机构）
    • 按地区
    • 按公司划分 (2022)
  • 市场地图

第 6 章：北美感染监测解决方案市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 透过提供
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲感染监测解决方案市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 透过提供
    • 按最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙

第 8 章：亚太地区感染监测解决方案市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 透过提供
    • 按最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第 9 章：南美洲感染监测解决方案市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 透过提供
    • 按最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲感染监测解决方案市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 透过提供
    • 按最终用户
    • 按国家/地区
  • MEA：国家分析
    • 南非感染监测解决方案
    • 沙乌地阿拉伯感染监测解决方案
    • 阿联酋感染监测解决方案

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：全球感染监控解决方案市场：SWOT 分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 服务内容
  • 最近的发展
  • 主要人员
  • SWOT分析
    • Cerner Corporation
    • Epic Systems Corporation
    • VigiLanz Corporation
    • Becton, Dickinson and Company
    • Premier Inc.
    • DEB Group Ltd
    • RL Solutions
    • Baxter International Inc. (ICNet International)
    • Gojo Industries Inc.
    • IBM Corporation (Truven Health Analytics)

第 16 章：策略建议

第 17 章：关于我们与免责声明

简介目录
Product Code: 4823

Global Infection Surveillance Solutions Market has valued at USD 557.21 Million in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 9.86% through 2028. An infection surveillance solution is a software used by healthcare facilities, including hospitals, to report patient data to state and federal authorities. These solutions play a crucial role in the healthcare industry by collecting data on nosocomial infections, studying infection patterns, and regulating their spread within the community. Nosocomial infections are infections transmitted to individuals within hospitals or healthcare centers. This software promptly alerts hospital Internet Protocol (IP) addresses in the event of infection occurrences. This enables HAI specialists and nurses to promptly provide appropriate treatment to infected patients, preventing outbreaks. Infection surveillance solutions are vital programs that facilitate the effective management of Healthcare-Acquired Infections (HAIs) in healthcare facilities. Common examples of HAIs include pneumonia, gastrointestinal illness, urinary tract infections, primary bloodstream infections, and post-surgical infections. The high incidence of HAIs is a significant concern for governments worldwide, leading to the development of policies aimed at effectively managing and reducing these incidents.

Key Market Drivers

Increasing Prevalence of Hospital-Acquired Infections

Market Overview
Forecast Period2024-2028
Market Size 2022USD 557.21 Million
Market Size 2028USD 975.33 Million
CAGR 2023-20289.86%
Fastest Growing SegmentHospitals
Largest MarketNorth America

The increasing prevalence of hospital-acquired infections (HAIs) is driving the demand for infection surveillance solutions. Hospital-acquired infections, also known as healthcare-associated infections, are infections that patients acquire while receiving medical treatment in healthcare facilities. These infections can lead to prolonged hospital stays, increased healthcare costs, patient discomfort, and, in severe cases, even mortality. In response to this growing concern, infection surveillance solutions are being sought after to help prevent, monitor, and manage HAIs. HAIs pose a significant threat to patient safety and well-being. The rising awareness of these concerns has prompted healthcare facilities to prioritize infection control.

The increasing emphasis on hospital safety is driving the market for infection control surveillance solutions. Hospitals are actively seeking ways to enhance patient safety and reduce infection rates through improved surveillance strategies. This transformation commenced in the late 2000s with the introduction of electronic medical record systems, which allowed for more efficient and accurate patient data collection. Presently, hospitals are investing in advanced solutions to detect and predict infections, implement evidence-based protocols, and monitor outcomes over time. These solutions leverage data analytics, AI, ML, and predictive modeling to facilitate accurate identification and mitigation of infection risks. Apart from enhancing patient safety, these solutions offer potential benefits such as cost reduction, operational efficiency improvement, and optimization of care quality.

Increasing Number of Surgeries

The increasing number of surgeries is driving the demand for infection surveillance solutions. Surgeries, while often necessary for medical treatment, carry a risk of post-operative infections, which can lead to complications, extended hospital stays, increased healthcare costs, and patient discomfort. Infection surveillance solutions play a critical role in monitoring and preventing healthcare-associated infections (HAIs), including those that occur after surgical procedures. Surgical procedures can introduce pathogens into the body, increasing the risk of infections at the surgical site. Infection surveillance solutions help healthcare facilities monitor surgical sites and detect infections early, leading to prompt interventions. Surgical site infections can lead to complications such as wound dehiscence, sepsis, and prolonged recovery. Effective infection surveillance solutions aid in preventing these complications, improving patient outcomes. Surgeons and healthcare professionals rely on data-driven insights to make informed decisions. Infection surveillance solutions provide real-time data and analytics to monitor infection trends, identify potential outbreaks, and inform clinical decisions. The increasing number of surgeries amplifies the importance of infection surveillance solutions in preventing post-operative infections and improving patient outcomes. As healthcare facilities recognize the impact of infection control on patient safety, quality of care, and financial sustainability, the demand for these solutions is expected to continue to rise.

Growing Government Initiatives & Investment in IPC Programs Across Healthcare Settings

Infection surveillance solutions are utilized in healthcare settings to empower healthcare professionals in predicting and preventing the transmission of infectious diseases. By early detection, evaluating intervention effectiveness, and identifying risk reduction tools, these solutions play a crucial role. Governments worldwide are implementing policies and regulations to develop long-term prevention programs and educate healthcare providers on infection prevention and control best practices. In addition to maintaining public statistical records, governments offer funding to healthcare centers and organizations for advanced infection surveillance software installation. These initiatives enable healthcare facilities of varying sizes to efficiently utilize cutting-edge tools, contributing to the growth of the infection control surveillance solutions market.

Growing Investments to Improve Healthcare Systems by AI integration

Investments in healthcare systems often prioritize patient safety and quality of care. Infection surveillance solutions play a vital role in identifying and preventing healthcare-associated infections (HAIs), thus contributing to improved patient safety outcomes. Healthcare systems are focusing on quality improvement initiatives to reduce adverse events, including HAIs. Infection surveillance solutions provide real-time monitoring, data analysis, and early detection of potential outbreaks, supporting these initiatives. HAIs lead to increased healthcare costs due to prolonged hospital stays, additional treatments, and readmissions. Investments in infection surveillance solutions can lead to significant cost savings by preventing infections and their associated complications.

Cloud-based and AI-integrated infection surveillance and control software is a critical technology that empowers public health organizations to swiftly and effectively detect and respond to infections. Over the years, advancements in cloud-based and AI-integrated software have significantly enhanced the efficacy and efficiency of infection surveillance and control. By leveraging cloud-based solutions, public health organizations can efficiently and securely store and manage large volumes of data. Furthermore, real-time access to this data enables more responsive action during outbreaks. Another notable progress in cloud-based and AI-integrated infection surveillance and control software is the integration of machine learning algorithms. These algorithms enable public health organizations to derive more comprehensive insights from the data, facilitating a better understanding of underlying infection patterns and informed response strategies.

Key Market Challenges

High Cost of Deployment for Small Healthcare Organizations

The high cost of deployment for small healthcare organizations is a significant factor restraining the growth of Infection Surveillance Solutions (ISS). These solutions often require initial investment in technology, infrastructure, staff training, and ongoing maintenance. For small healthcare organizations with limited budgets and resources, the cost of implementing and sustaining infection surveillance solutions can be a barrier to adoption. Small healthcare organizations often operate with tighter budgets compared to larger institutions. The high upfront and ongoing costs associated with infection surveillance solutions can strain their financial resources, making it difficult to allocate funds for implementation. Small healthcare organizations may need to prioritize their resources for essential services and treatments. Investing in infection surveillance solutions might divert resources away from other critical needs, making the decision challenging. Beyond the initial deployment, infection surveillance solutions require ongoing maintenance, updates, and technical support. Small healthcare organizations might struggle to allocate resources for these continuous operational needs.

Data Security Concerns

Infection surveillance solutions require the collection and storage of patient health data, including personal and medical information. Ensuring the privacy of this data is crucial to maintain patient trust and comply with regulations like the Health Insurance Portability and Accountability Act (HIPAA) in the United States. Healthcare organizations are subject to strict data protection regulations and standards, which can vary by region. Failure to comply with these regulations can lead to severe penalties. Implementing ISS while ensuring compliance adds complexity and cost to the process. The software and hardware used in ISS solutions can have vulnerabilities that hackers could exploit to gain unauthorized access. Addressing these vulnerabilities requires continuous monitoring, updates, and security measures. Many ISS solutions involve third-party vendors and cloud services for data storage and management. This introduces additional security concerns, as healthcare organizations need to trust that these vendors have robust security measures in place.

Key Market Trends

Cloud-based Software Solutions

Cloud-based software solutions are expected to significantly boost the Infection Surveillance Solutions (ISS) market in the future. Cloud technology offers a range of benefits that align well with the needs of healthcare organizations seeking efficient and scalable infection surveillance solutions. Cloud-based solutions offer scalability to accommodate the varying needs of healthcare organizations, whether they are small clinics or large hospitals. As the demand for infection surveillance solutions grows, cloud platforms can easily scale up to handle increased data volume and user activity. Traditional on-premises software solutions require significant investments in hardware, servers, and IT infrastructure. Cloud-based solutions eliminate these upfront costs, making ISS more accessible to healthcare organizations with limited resources. Cloud-based solutions are typically quicker to implement compared to on-premises alternatives. This is particularly advantageous for healthcare organizations looking to deploy infection surveillance solutions rapidly. Cloud-based solutions provide remote access to infection surveillance data for authorized personnel. Healthcare professionals can securely access and monitor infection data from various locations, enabling more efficient and timely interventions. Cloud-based infection surveillance solutions enable real-time monitoring of infection trends, allowing healthcare organizations to respond promptly to potential outbreaks and implement necessary interventions.

Increasing Consolidation in The Healthcare Industry

Increasing consolidation in the healthcare industry is expected to boost the Infection Surveillance Solutions (ISS) market in the future. Healthcare industry consolidation refers to the merging of hospitals, healthcare systems, and medical facilities into larger entities. As healthcare organizations consolidate, there is a greater focus on standardizing practices across different facilities. This includes infection control protocols and the adoption of common technology solutions like ISS to ensure consistent monitoring and management of infections. Consolidated healthcare entities often seek to integrate and share patient data seamlessly. Infection surveillance solutions that offer interoperability and data sharing capabilities are crucial for tracking infections across different departments and locations.

Segmental Insights

Product Type Insights

Based on the offering, the market is categorized into software and services. In 2022, the software segment dominated the market. Conversely, the services segment is projected to demonstrate a higher Compound Annual Growth Rate (CAGR) during the forecast period, owing to the increased adoption of software packages in healthcare facilities. The software segment is expected to witness the highest CAGR throughout the forecast period. This growth can be attributed to its advantages over on-premises software, including availability in different configurations, rapid return on investment, and real-time analysis. Furthermore, healthcare IT companies are introducing innovative solutions in data management, analytics, and infrastructure, facilitating easier data collection of electronic health records (EHR), infection, and epidemic trends through their software packages.

End User Insights

The infection surveillance solutions market, categorized by end user, is divided into hospitals, and long-term care facilities. Among these, the hospitals segment holds the largest market share and exhibits the highest growth rate during the forecast period. The significant prevalence of healthcare-associated infections (HAIs) and the subsequent financial burden on stakeholders have propelled the adoption of infection control products and services in hospitals. Additionally, the substantial patient volume and the increasing incidence of surgical site infections (SSIs) contribute to the market's growth. Notable HAIs commonly reported in hospitals include central line-associated bloodstream infections, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci bloodstream infections, Clostridium difficile infections, and SSIs.

Regional Insights

The North American region has demonstrated dominance in market share compared to other regions. This can be attributed to strict regulations and the presence of numerous firms offering infection surveillance solutions in the region. The government's substantial investment in healthcare has led to an increase in the number of healthcare centers. On the other hand, the APAC region is experiencing the highest growth rate. This can be attributed to increased health awareness, higher healthcare expenditure, a growing number of healthcare centers, and significant improvements in health insurance.

Key Market Players

  • Cerner Corporation
  • Epic Systems Corporation
  • VigiLanz Corporation
  • Becton, Dickinson and Company
  • Premier Inc.
  • DEB Group Ltd
  • RL Solutions
  • Baxter International Inc. (ICNet International)
  • Gojo Industries Inc.
  • IBM Corporation (Truven Health Analytics)

Report Scope:

In this report, the Global Infection Surveillance Solutions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Infection Surveillance Solutions Market, By Offering:

  • Software
  • Service

Infection Surveillance Solutions Market, By End User:

  • Hospitals
  • Long-term Care Facilities

Infection Surveillance Solutions Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Infection Surveillance Solutions Market.

Available Customizations:

  • Global Infection Surveillance Solutions market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Infection Surveillance Solutions Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Offering (Software, Service)
    • 5.2.2. By End User (Hospitals, Long-term Care Facilities)
    • 5.2.3. By Region
    • 5.2.4. By Company (2022)
  • 5.3. Market Map

6. North America Infection Surveillance Solutions Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Offering
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Infection Surveillance Solutions Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Offering
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Infection Surveillance Solutions Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Offering
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Infection Surveillance Solutions Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Offering
        • 6.3.3.2.2. By End User

7. Europe Infection Surveillance Solutions Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Offering
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Infection Surveillance Solutions Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Offering
        • 7.3.1.2.2. By End User
    • 7.3.2. United Kingdom Infection Surveillance Solutions Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Offering
        • 7.3.2.2.2. By End User
    • 7.3.3. Italy Infection Surveillance Solutions Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Offering
        • 7.3.3.2.2. By End User
    • 7.3.4. France Infection Surveillance Solutions Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Offering
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Infection Surveillance Solutions Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Offering
        • 7.3.5.2.2. By End User

8. Asia-Pacific Infection Surveillance Solutions Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Offering
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Infection Surveillance Solutions Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Offering
        • 8.3.1.2.2. By End User
    • 8.3.2. India Infection Surveillance Solutions Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Offering
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Infection Surveillance Solutions Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Offering
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Infection Surveillance Solutions Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Offering
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Infection Surveillance Solutions Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Offering
        • 8.3.5.2.2. By End User

9. South America Infection Surveillance Solutions Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Offering
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Infection Surveillance Solutions Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Offering
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Infection Surveillance Solutions Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Offering
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Infection Surveillance Solutions Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Offering
        • 9.3.3.2.2. By End User

10. Middle East and Africa Infection Surveillance Solutions Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Offering
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Infection Surveillance Solutions Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Offering
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Infection Surveillance Solutions Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Offering
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Infection Surveillance Solutions Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Offering
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Infection Surveillance Solutions Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Cerner Corporation
    • 15.5.2. Epic Systems Corporation
    • 15.5.3. VigiLanz Corporation
    • 15.5.4. Becton, Dickinson and Company
    • 15.5.5. Premier Inc.
    • 15.5.6. DEB Group Ltd
    • 15.5.7. RL Solutions
    • 15.5.8. Baxter International Inc. (ICNet International)
    • 15.5.9. Gojo Industries Inc.
    • 15.5.10. IBM Corporation (Truven Health Analytics)

16. Strategic Recommendations

17. About Us & Disclaimer